Samuel Keller is currently a Translational Science Lead at PathAI, where they apply their expertise in immunology, gene expression, and multi-omics to drive innovative solutions in the pharmaceutical and biotech sectors. Previously, they served as a Post Doc Fellow in Infectious Diseases and Vaccines at Merck and gained valuable experience through various co-op positions at The Janssen Pharmaceutical Companies of Johnson & Johnson and The Dow Chemical Company. Samuel earned a Doctor of Philosophy (PhD) from the University of Pennsylvania and holds a Bachelor's degree from Rensselaer Polytechnic Institute, equipping them with a solid foundation in scientific research and data analysis.
Location
Boston, United States